Alex Lobo | Investor Relations |
Milton Werner | Chief Executive Officer |
Joe Frattaroli | Chief Financial Officer |
Ed White | H.C. Wainwright |
Good morning. Welcome to the Inhibikase Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Alex Lobo, Stern Investor Relations. Please go ahead.